Pioneer of Poly Scientific Ayurveda (PSA) Dr Ravishankar Polisetty, emphasises the integration of traditional medicine into the National Health Strategy

Ahmedabad (Gujarat) [India] March 22: The widespread acceptance of Ayurveda, alongside other traditional medicinal practices, has provided a boost to the Ayush sector globally. According to the Union Government’s projection, the Indian Ayush sector has secured a market of no less than USD 23 billion in 2023. Within this, the Ayurvedic sector alone is experiencing substantial growth. Industry experts attribute this success to Prime Minister Narendra Modi’s vision, emphasising the integration of Ayurvedic principles into modern healthcare and the promotion of research. This approach has strategically positioned Ayurveda as a beacon of holistic wellness on both national and international fronts.

“The government’s comprehensive approach extends beyond domestic initiatives, as evidenced by the global promotion of Ayurveda. The recognition of Ayurveda as a traditional medical system by more than 30 countries is a testament to diplomatic efforts and collaborations, positioning India as a leader in alternative medicine on the international stage,” says Dr Ravishankar Polisetty, a pioneer in Poly Scientific Ayurveda (PSA).
 
He says that the support from the centre will assist more startups and medical experts in developing novel innovations that blend the ancient wisdom of Ayurveda with contemporary technical advancements.
 
“The Prime Minister had already emphasized that, more than an alternative, Ayurveda is now a fundamental pillar in the national health policy. He envisions establishing 1.5 lakh Health and Wellness Centres nationwide under the Ayushman Bharat Yojana, with 12,500 centres specifically dedicated to Ayush Wellness to promote integrative medicine systems. These developments are going to make significant changes in India’s healthcare sector,” adds Dr Polisetty.

A versatile cardiac surgeon, ayurvedic researcher, and data scientist, Dr Polisetty is the founder of Sai Ganga Panakeia Private Limited (SGP) and Novadigm Health Inc (Delaware), a global leader in biotechnology and personalised medicine.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Health

Sakra World Hospital Breaks Records with 275 Plus Joint Replacement Surgeries in May

Bengaluru (Karnataka) [India], June 20:  Sakra World Hospital, Bengaluru, has achieved a remarkable milestone by completing over 425 orthopedic surgeries in May. Under the expert leadership of Dr. Chandrashekar P., Director of Orthopedics, the 15-membered orthopedic team has made history by setting a new standard in the state of Karnataka. The team performed 275+ joint replacements, the highest […]

Read More
Health

Samad Hussain Patanwala Redefining Pharma Manufacturing with Den Mark Pharmaceuticals

Mumbai (Maharashtra) [India], June 19: Samad Hussain Patanwala is a vibrant, visionary leader. With a solid history in pharmaceutical distribution, Samad has been important in propelling the firm to new heights of success. Den Mark Pharmaceuticals has developed rapidly under his supervision, becoming a well-known distributor in India and worldwide. With a strong emphasis on digital […]

Read More
Health

Samad Hussain Patanwala’s Den Mark Pharmaceuticals Leads in Pharma Manufacturing Excellence

Mumbai (Maharashtra) [India], June 19: Samad Hussain Patanwala, a passionate and ambitious entrepreneur, has over 9 years of experience in the pharmaceutical sector and intends to bring high-quality and inexpensive pharmaceuticals to overlooked markets worldwide. With a BMS degree in Business Administration and Management and a solid pharmaceutical distribution and marketing foundation, he started Den Mark […]

Read More